Literature DB >> 16684598

Novel spastin (SPG4) mutations in Italian patients with hereditary spastic paraplegia.

Angela Magariello1, Maria Muglia, Alessandra Patitucci, Rosalucia Mazzei, Francesca Luisa Conforti, Anna Lia Gabriele, Teresa Sprovieri, Carmine Ungaro, Antonio Gambardella, Michelangelo Mancuso, Gabriele Siciliano, Damiano Branca, Umberto Aguglia, Maria Vittoria de Angelis, Katia Longo, Aldo Quattrone.   

Abstract

Spastic paraplegia type 4 is caused by mutations in the gene that encodes spastin (SPG4), a member of the AAA protein family. A cohort of 34 unrelated Italian patients with pure spastic paraplegia, of which 18 displayed autosomal dominant inheritance and 16 were apparently sporadic, were screened for mutations in the SPG4 gene by denaturing high performance liquid chromatography. We identified a previously reported mutation in a sporadic patient with pure hereditary spastic paraplegia. We also identified eight unrelated patients with pure autosomal dominant hereditary spastic paraplegia carrying five novel mutations in the SPG4 gene (one missense mutation, c.1304 C>T; one nonsense mutation, c.807C>A; two frameshift mutations, c.1281dupT, c.1514_1515insATA; and one splicing mutation, c.1322-2A>C). The frequency for SPG4 mutations detected in autosomal dominant hereditary spastic paraplegia was 44.4%. This study contributes to expand the spectrum of SPG4 mutations in Italian population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16684598     DOI: 10.1016/j.nmd.2006.03.009

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  3 in total

1.  Autosomal dominant hereditary spastic paraplegia: report of a large Italian family with R581X spastin mutation.

Authors:  P Aridon; P Ragonese; M De Fusco; D Lo Coco; G Salemi; G Casari; G Savettieri
Journal:  Neurol Sci       Date:  2007-08-10       Impact factor: 3.307

2.  The investigation of genetic and clinical features in patients with hereditary spastic paraplegia in central-Southern China.

Authors:  Chen Wang; Yun-Jian Zhang; Ci-Hao Xu; Zhi-Jun Liu; Yan Wu
Journal:  Mol Genet Genomic Med       Date:  2021-02-27       Impact factor: 2.183

3.  Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis.

Authors:  Xiaoming Jia; Lohith Madireddy; Stacy Caillier; Adam Santaniello; Federica Esposito; Giancarlo Comi; Olaf Stuve; Yuan Zhou; Bruce Taylor; Trevor Kilpatrick; Filippo Martinelli-Boneschi; Bruce A C Cree; Jorge R Oksenberg; Stephen L Hauser; Sergio E Baranzini
Journal:  Ann Neurol       Date:  2018-07-03       Impact factor: 10.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.